Journal
REGULATORY PEPTIDES
Volume 164, Issue 2-3, Pages 151-157Publisher
ELSEVIER
DOI: 10.1016/j.regpep.2010.05.017
Keywords
VIP; NEP; Asthma; Columnar epithelia; Smooth muscle; Immunohistochemistry
Categories
Funding
- NIH/NCRR2P20 [RR015566]
- NIAID/NIH [1R15AI69061]
- NDSU [NSF HRD-0811239]
Ask authors/readers for more resources
Vasoactive intestinal peptide (VIP) is a neuropeptide with cytokine properties that is abundant in the lung. VIP null mice exhibit spontaneous airway inflammation and hyperresponsiveness emphasizing VIP's anti-asthma potential. Although VIP's impending protective role in the lung has been demonstrated, its localization in the naive and allergic murine lungs has not. To this aim, we analyzed the availability of VIP and its protease, neutral peptidase (NEP), in naive and Aspergillus-sensitized and challenged murine lungs after 3, 7, and 14 days. Both VIP and NEP were predominantly localized to the columnar epithelia of the airways in naive lungs. A marked decrease in VIP occurred in these cells 3 days after allergen challenge. NEP localization in the columnar epithelia decreased after allergen challenge. At day 14, VIP localization in the columnar epithelia and arteriolar smooth muscle increased while NEP localization at these sites remained low. This study provides new insights into the local regulation of VIP in the columnar epithelia of the allergic lung. Its altered availability in the context of allergy provides fresh evidence for the modulation of pulmonary inflammation by VIP. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available